Praxis Precision Medicines, Inc. 10-Q

Item 5. Other Information. None 80 Table of Contents Item 6. Exhibits. Exhibit Number Description 3.1 Amended and Restated Certificate of Incorporation of Praxis Precision Medicines, Inc. (incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K (File No. 001-39620) filed on October 20, 2020). 3.2 Amended and Restated Bylaws of Praxis Precision Medicines, Inc. (incorporated by reference to Exhibit 3.2 to the Registrant’s Form 8-K (File No. 001-39620) filed on October 20, 2020). 4.1 Specimen stock certificate evidencing the shares of common stock (incorporated by reference to Exhibit 4.1 to our Registration Statement on Form S-1/A (File No. 333-249074) filed with the SEC on October 9, 2020). 4.2 Fourth Amended and Restated Investors’ Rights Agreement among Praxis Precision Medicines, Inc. and certain of its stockholders, effective as of July 24, 2020 (incorporated by reference to Exhibit 4.2 to our Registration Statement on Form S-1 (File No. 333-249074) filed with the SEC on September 25, 2020). 10.1 Form of Director Indemnification Agreement, as amended (incorporated by reference to Exhibit 10.1 to our Registration Statement on Form S-1/A (File No. 333-249074) filed with the SEC on October 9, 2020). 10.2 Form of Officer Indemnification Agreement (incorporated by reference to Exhibit 10.2 to our Registration Statement on Form S-1 (File No. 333-249074) filed with the SEC on September 25, 2020). 10.3# Praxis Precision Medicines, Inc. 2020 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10.4 to our Registration Statement on Form S-1/A (File No. 333-249074) filed with the SEC on October 9, 2020). 10.4# Form of Incentive Stock Option Agreement under 2020 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10.5 to our Registration Statement on Form S-1/A (File No. 333-249074) filed with the SEC on October 9, 2020). 10.5# Form of Non-Qualified Stock Option Agreement for Company Employees under 2020 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10.6 to our Registration Statement on Form S-1/A (File No. 333-249074) filed with the SEC on October 9, 2020). 10.6# Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under 2020 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10.7 to our Registration Statement on Form S-1/A (File No. 333-249074) filed with the SEC on October 9, 2020). 10.7# Form of Restricted Stock Award Agreement under 2020 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10.8 to our Registration Statement on Form S-1/A (File No. 333-249074) filed with the SEC on October 9, 2020). 10.8# Form of Restricted Stock Award Agreement for Company Employees under 2020 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10.9 to our Registration Statement on Form S-1/A (File No. 333-249074) filed with the SEC on October 9, 2020). 10.9# Form of Restricted Stock Award Agreement for Non-Employee Directors under 2020 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10.10 to our Registration Statement on Form S-1/A (File No. 333-249074) filed with the SEC on October 9, 2020). 10.10# Praxis Precision Medicines, Inc. 2020 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.11 to our Registration Statement on Form S-1/A (File No. 333-249074) filed with the SEC on October 9, 2020). 81 Table of Contents 10.11*# Form of Amended and Restated Employment Agreement. 10.12# Non-Employee Director Compensation Policy (incorporated by reference to Exhibit 10.13 to our Registration Statement on Form S-1/A (File No. 333-249074) filed with the SEC on October 9, 2020). 31.1* Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2* Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.1** Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 101.INS* XBRL Instance Document 101.SCH* XBRL Taxonomy Extension Schema Document 101.CAL* XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF* XBRL Taxonomy Extension Definition Linkbase Document 101.LAB* XBRL Taxonomy Extension Label Linkbase Document 101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document * Filed herewith. ** The certifications furnished in Exhibit 32.1 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference. # Indicates a management contract or any compensatory plan, contract or arrangement. 82 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Company Name Date: November 23, 2020 By: /s/ Marcio Souza Marcio Souza Chief Executive Officer and Director (Principal Executive Officer) Date: November 23, 2020 By: /s/ Stuart Chaffee Stuart Chaffee, Ph.D. Chief Financial Officer (Principal Financial Officer) 83